research proposal (m04ekm)- syed shah areeb hussain - 0541198
Post on 02-Jun-2018
250 Views
Preview:
TRANSCRIPT
-
8/10/2019 Research Proposal (M04EKM)- Syed Shah Areeb Hussain - 0541198
1/14
RESEARCH PROPOSAL
M04 EKM
EVALUATING THE EFFICACY OF cGMP-LEAN INTEGRATED TECHNOLOGIES IN
IMPROVING QUALITY AND COST IN PHARMACEUTICAL MANUFACTURING A
CASE STUDY
SYED SHAH AREEB HUSSAIN0541198
-
8/10/2019 Research Proposal (M04EKM)- Syed Shah Areeb Hussain - 0541198
2/14
TABLE OF CONTENTS
Abstract.........................................................................................................1
Aim of the Study ..2
Objectives of the Study2
Project Deliverables ..2
Significance of the Research3
Research Methodology ....3
Data Sources
..6Draft Headings ..7
Task Schedules ..9
Gantt Chart12
References .13
-
8/10/2019 Research Proposal (M04EKM)- Syed Shah Areeb Hussain - 0541198
3/14
EVALUATING THE EFFICACY OF cGMP-LEAN INTEGRATED TECHNOLOGIES IN
IMPROVING QUALITY AND COST IN PHARMACEUTICAL MANUFACTURING A
CASE STUDY
ABSTRACT
The purpose of this paper is to combine the lean manufacturing techniques with the current
good manufacturing practices (cGMP) and analyse its efficacy in a pharmaceutical
manufacturing setting. Implementing lean in the pharmaceutical sector has been met with
several complications due to stringent quality control requirements (Lanez et al. 2012).
Though cGMP principles are often are often viewed as contrary to those of lean
manufacturing, one can be used to support the other and therefore can complement each
other (O'Rourke & Greene, 2006). This study will analyse the current issues faced while
implementing lean into the pharmaceutical sector and attempt to address these problems by
associating it with cGMP principles. This will be done by implementing these principles within
a pharmaceutical company and assisting them in reducing their lead times, cycle times and
first yield quality pass rates. The results obtained in this study could be used as a standard for
efficient implementation of these technologies in the pharmaceutical sector.
-
8/10/2019 Research Proposal (M04EKM)- Syed Shah Areeb Hussain - 0541198
4/14
AIM OF THE STUDY
The aim of the study is to relate cGMP to lean manufacturing techniques which can be
implemented in the production line of a pharmaceutical company, and to evaluate thee
efficacy of these principles in improving quality while reducing costs in the company.
OBJECTIVES
To identify and relate relevant cGMP and lean manufacturing principles that can be
effectively implemented in a pharmaceutical manufacturing sector
To analyse the current production process in the factory floor and identify key areas
of improvements
To develop and suggest improvements based on the cGMP-Lean combined principles
within the manufacturing process
To measure the variables governing quality, cost and time in the improved
manufacturing process
To evaluate the efficacy of the developed principles and techniques in improving
quality, cost and time analysing the results with respect to similar case studies
performed
PROJECT DELIVERABLES
Literature review highlighting the key concepts of cGMP and lean manufacturing and
their relation to pharmaceutical manufacturing
Enumeration of cGMP and Lean principles and techniques that can be applied in
relation to each other to the pharmaceutical manufacturing process
Current state map of the current process methods with yamazumi boards, pareto
chart and spaghetti diagrams providing details of the processes
Future state map of suggested techniques to be implemented with yamazumi boards,
standard op sheets and negare cell walk diagrams to provide details of improvements
Gantt chart and implementation plan for the integration of the techniques to the
current process flow
Table highlighting the changes in the variables defining quality, cost and timemeasured before and after the implementation of strategies
Critical Analysis of cGMP-Lean principles in improving quality and cost while reducing
time in the pharmaceutical manufacturing process
-
8/10/2019 Research Proposal (M04EKM)- Syed Shah Areeb Hussain - 0541198
5/14
SIGNIFICANCE OF THE RESEARCH
Stringent quality control regulations and growing complexity of diseases have led to the
increased costs in pharmaceutical manufacturing industries (DiMasi et al. 2003). While on one
hand, other technological sectors have greatly reduced their operating costs to provide the
best products at a reasonable price, the cost of production of medicines has only increased.This is in part due to the lean manufacturing technology that is now implemented in almost
all other manufacturing industry. Previous studies have shown that lean manufacturing
principles can be modified and made concurrent with the pharmaceutical manufacturing
requirements to develop efficient manufacturing systems (Thomas 2005). However, often the
application of these techniques undermine the cGMP regulations (Dermot and Greene 2006).
Therefore there is a need to identify an integrated approach that combines the common
elements of lean manufacturing and cGMP guidelines.
The proposed research aims to develop a cGMP-Lean combined approach towards lean
manufacturing, which will then be applied in a production line of the selected pharmaceuticalcompany improve the cost and quality efficiencies. The results obtained from this study would
be applicable to any pharmaceutical organization and is expected to provide effective cost
reduction and improved quality.
As a biotechnology engineering graduate, the optimization of the pharmaceutical
manufacturing process is one of my key interests, which has strongly influenced my selection
of the research project.
RESEARCH METHODOLOGY
The proposed research requires the use of both quantitative and qualitative research
methodologies. Qualitative research methodologies are concerned with individual
perspective and focus on drawing conclusions through discussions. On the other hand
quantitative research methods focus on absolute data and draw conclusions through
quantifiable data. The proposed research would require qualitative research methods in
order to obtain inputs from the factory operators on the applicability of the techniques. On
the other hand, quantifiable data related to cost, time and quality measurements will be usedto critically analyse the efficacy of the introduced techniques.
Literature Review Qualitative
A literature review highlighting the various cGMP and lean manufacturing techniques will be
produced. This will be done through qualitative analysis of the current advancement in these
technologies and will highlight the different advantages and challenges of said technologies.
A few case studies have been performed on the implementation of lean in the pharmaceutical
industry (Chowdary and George 2011, Carleysmith et al. 2009, Weller et al. 2006). These case
studies will be discussed in detail and will be used for reference for critical analysis with
respect to a cGMP-Lean combined approach.
-
8/10/2019 Research Proposal (M04EKM)- Syed Shah Areeb Hussain - 0541198
6/14
Enumeration of cGMP-Lean techniques Qualitative
The literature review will be followed by the selection of appropriate lean and cGMP
techniques to be implemented in a selected production line at the designated pharmaceutical
manufacturing company. cGMP guidelines and lean manufacturing principles are often
viewed as opposed to each other because while the former focuses on increased qualitychecks, the latter focuses on reduced wastes. However, the underlying concepts of these two
principles is the same that is to add value to the produce. Moreover, they share some
common ground as both are concerned with implementing standard operating procedures,
continuous improvement and flow within the process (Dermot and Greene 2006). Therefore
development of the techniques will require a qualitative analysis of these underlying
concepts, their relation and validity for application in pharmaceutical manufacturing.
Current State Map Quantitative
The Current state map is often the first tool used for implementing the lean principles. The
current state map provides a broad view of the current processes and the process stream
(Rother and Shook 2003). Developing the current state map will require quantitative
methodology in the form of data such as cycle times, inventory etc. that are obtained through
observation of measurement of variables at each of the processes within the selected
production line. The data collected will then be used to create a complete picture of the
process stream.
Future State Map Mixed
The next step in lean manufacturing is formation of the future state map, which defines what
the process should look like in the future after implementation of lean techniques. This willrequire both qualitative and quantitative research methodologies.
Firstly, the cGMP-Lean principles need to be discussed with the factory floor workers to verify
their validity and applicability to the process. This will require discussions in focus group to
identify areas of improvement and implement strategies.
Secondly, optimizations in the process using the cGMP-Lean techniques will be measured to
produce quantifiable data, which will be used to calculate the different variables in the future
state map (Rother and Shook 2003).
Implementation Plant and Gantt Chart Mixed
The implementation plans will be produced based on the present data to ensure sufficient
time allowance. This will be done through discussions with the production line manager as
well as data collected in the initial stages.
Critical Analysis Qualitative
Mukhopadhyay et al. (1998) were the first to suggest implementation of lean manufacturing
techniques through an integrated approach to the pharmaceutical manufacturing. In recent
years several other case studies have been performed on implementation of lean within the
pharmaceutical industry (Weller et al. 2006, Carleysmith et al. 2009, Chowdary and George2011). However, these case studies have not attempted to integrated cGMP practices to lean
-
8/10/2019 Research Proposal (M04EKM)- Syed Shah Areeb Hussain - 0541198
7/14
manufacturing. The proposed research will explore the benefits of this integration as
compared to the previous work and critically analyse the various aspects of this approach.
Though the research methods to be employed are expected to produce the desired results,
several factors may hamper the effective analysis of data. Firstly, resistance to change can be
a key factor in reducing the involvement of factory workers and plant managers in focus
groups. This will greatly affect the ideas proposed and therefore reduce the effective
implementation. These problems can be overcome by efficiently communicating the need to
implement the change in the organization and the benefits the new system would provide.
Secondly, often sole quantitative analysis may not be sufficient in producing the current state
map as it may be necessary to discuss the variable related to machines being used for several
different products. In this case a discussion with the operator would be required to identify
cycle times and inventories for a specific product as these are not clearly visible.
DATA SOURCES
The literature review will require mostly secondary data sources such as books, case studies
and journal articles. These will be obtained through the Lanchester library at Coventry
University.
The current state map will be developed through observations and discussions. Therefore it
would mostly involve primary data sources.
The Future state map will require both primary and secondary data sources. While previously
conducted research and case studies need to be used for developing ideas for improvement,
the feedback from operators in focus groups will also be needed to effectively implement
these techniques.
Gantt chart, implementation plans and the quality, cost and time measurement tables will
require the use of primary sources of data. This is because it will require going to the factory
floor and personally measuring the different variables in the process through observations
and discussions.Finally both primary and secondary sources of data will be used for the critical analysis. The
primary sources used for this will be the different measurements of improvement that are to
be calculated. The secondary sources will be case studies and previous researches with which
the current case study needs to be compared.
-
8/10/2019 Research Proposal (M04EKM)- Syed Shah Areeb Hussain - 0541198
8/14
Draft Headings
1 Introduction
1.1 Background
1.2 Aim
1.3 Research Objective
1.4 Scope and Benefit
1.5 Limitations of the Study
2 Literature Review
2.1 Current Good Manufacturing Practices
2.1.1 What is cGMP
2.1.2 Need for cGMP
2.1.3
Regulations based on cGMP2.1.4 Other Good Practices (GLP, GCP, GRP)
2.2 Lean Manufacturing Principles
2.2.1 Value Stream Mapping
2.2.2 Pareto Analysis
2.2.3 Yamazumi Board
2.2.4 Spaghetti Diagram
2.2.5 Cell Design
2.2.6 Nagare cells and walk diagrams
2.2.7
Workload sharing
2.3 Pharmaceutical Manufacturing
2.3.1 Current Practices in Pharmaceutical Manufacturing
2.3.2 Challenges faced in drug development
2.3.3 cGMP in Pharmaceutical manufacturing
2.3.4 Lean in pharmaceutical manufacturing
2.3.5 Combining cGMP with Lean
3 Research Methodology
3.1 Types of Research Tools Employed
3.2 Data Collection Methods
3.3 Data Analysis Tools
4 Case Study
4.1 About The Company
4.1.1 Current Problems faced by Company
4.1.2 Selection of Production Line
4.2 Root Cause Analysis
4.3 Pareto Analysis
-
8/10/2019 Research Proposal (M04EKM)- Syed Shah Areeb Hussain - 0541198
9/14
4.4 Current State Value Stream Map
4.5 Cell Design
4.6 Yamazumi Board
4.7 Future State Value Stream Map
5 Results
5.1 Lead Time reduction
5.2 First Yield Quality Pass Rate
5.3 Cost reduction analysis
6 Discussion
6.1 Improvements in the production line
6.2 Comparison with previous studies
6.3
Benefits of integration of cGMP with lean manufacturing principles6.4 Practical Validation
7 Conclusion
8 References
TASK SCHEDULES
Deliverable - Literature review highlighting the key concepts of cGMP and lean manufacturing and
their relation to pharmaceutical manufacturing
No. Tasks Days Dependency Re-
sources
Risks
1 Gather Literature 5 Library,
Computer
Library may
be closed
2 Read and Organize Literature 5 1, Com-
puter,
Books
Books may
be checked
out
3 Draft Section Headings 1 1, 2 Computer May Lose
data
4 Prepare Draft Literature Review 4 1, 2, 3 Computer May Lose
data5 Proof Read 1 1, 2, 3, 4 Computer May Lose
data
6 Apply corrections and prepare final version 1 1, 2, 3, 4, 5 Computer May Lose
data
Total 17
Deliverable - Enumeration of cGMP and Lean principles and techniques that can be applied in
relation to each other to the pharmaceutical manufacturing process
No. Tasks Days Dependency Re-
sources
Risks
-
8/10/2019 Research Proposal (M04EKM)- Syed Shah Areeb Hussain - 0541198
10/14
1 Collect relevant literature(books and jour-
nals)
3 Library,
Computer
Library may
be closed
2 Read and list all lean techniques 1 1, Computer May Lose
data
3 List all cGMP guidelines and regulations 1 1,2 ejournal
libraries4 Compare and contrast lean principles to
cGMP guidelines
4 1, 2, 3,
5 Select and integrate suitable principles from
lean and cGMP to develop a list of cGMP-
Lean techniques
4 1, 2, 3, 4
6 Discuss validity of techniques with plant
manager
1 1, 2, 3, 4, 5
7 Prepare final version of list 1
Total 15
Deliverable - Current state map of the current process methods with yamazumi boards, pareto chart
and spaghetti diagrams providing details of the processes
No. Tasks Days Dependency Re-
sources
Risks
1 Select Production line for case study 1
2 Prepare draft overview of the process stream
by walking along the stream
1 1,
3 Note down the WIP at each process 2 1, 2 Calculator Too much
WIP may be
difficult to
count
4 Discuss other process variables like cycle
times, quality pass rate and availability with
operators
1 1, 2, 3 Inaccuracy in
measure-
ments
5 Using data collected, prepare a rough current
state map while walking along the process
stream
5 1, 2, 3, 4 A3 Sheet,
Calculator
6 Proof read CSM 1 1, 2, 3, 4, 5
7 Apply corrections if necessary and prepare fi-
nal version
1 1, 2, 3, 4, 5, 6 Microsoft
Visio
Total 12
Deliverable - Future state map of suggested techniques to be implemented with yamazumi boards,
standard op sheets and negare cell walk diagrams to provide details of improvements
No. Tasks Days Dependency Re-
sources
Risks
1 Prepare Yamazumi Board and relate to takt
time
1 Excel
Spread-
sheet
2 Analyze current state map with respect to 7
wastes
1 1, Literature
review
-
8/10/2019 Research Proposal (M04EKM)- Syed Shah Areeb Hussain - 0541198
11/14
3 Discuss the problems of the current state
map with factory operators and production
line manager
2 1, 2 Recorder
4 Introduce previously developed cGMP-Lean
principles and identify areas for implementa-
tion
1 1, 2, 3
5 Carry out focus groups to analyze the validity
of principles with respect to the current pro-
cess
2 1, 2, 3, 4 Recorder
6 Perform Future state calculations 1 1, 2, 3, 4, 5 Calculator
7 Using data calculated and techniques pro-
duced, develop a draft Future State Map
3 1, 2, 3, 4, 5, 6 Microsoft
Visio
8 Proof Read and create final version 2 1, 2, 3, 4, 5,
6, 7
Total 13
Deliverable - Gantt chart and implementation plan for the integration of the techniques to the cur-
rent process flow
No. Tasks Days Dependency Re-
sources
Risks
1 Discuss implementation timelines with plant
manager
2 Resistance to
change
2 Prepare draft implementation plan 5 1, Excel
Spread-
sheet
3 Discuss validity of plan with plant manager 1 1, 2
4 Prepare Gantt chart for implementation 3 1, 2, 3 ExcelSpread-
sheet
5 Take steps to introduce the plan in a smooth
and timely manner
5 1, 2, 3, 4 Resistance to
change
Total 16
Deliverable -Table highlighting the changes in the variables defining quality, cost and time measured
before and after the implementation of strategies
No. Tasks Days Dependency Re-
sources
Risks
1 Measure the cycle time, changeover times,lead time, quality pass rate etc. for each pro-
cess
3 Inaccuracy inmeasure-
ments
2 Prepare a table to contrast current variables
after implementation of strategy with those
in the current state map
1 1, Excel
Spread-
sheet
3 Calculate the first pass yield, lead time and
perform cost analysis before and after imple-
mentation
3 1, 2 Calculator
4 Contrast the obtained values in a detailed ta-
ble
3 1, 2, 3
Total 10
-
8/10/2019 Research Proposal (M04EKM)- Syed Shah Areeb Hussain - 0541198
12/14
Deliverable - Critical Analysis of cGMP-Lean principles in improving quality and cost while reducing
time in the pharmaceutical manufacturing process
No. Tasks Days Dependency Re-
sources
Risks
1 Compare data from tables produced in the
results sections
5
2 Identify benefits of implementing the princi-
ples as compared to the traditional approach
2 1,
3 Compare the results with those obtained in
previous studies
5 1, 2
4 Highlight benefits of cGMP-Lean over rele-
vant literature
3 1, 2, 3
5 Identify the limitations of the research and
areas of further research
2 1, 2, 3, 4
6 Prepare draft Sections 3 1, 2, 3, 4, 5 Computer
7 Proof Read and perform corrections 1 1, 2, 3, 4, 5, 6 Computer
8 Prepare final version 3 1, 2, 3, 4, 5,
6, 7
Computer
Total 24
Total No. Of days = 107 days
-
8/10/2019 Research Proposal (M04EKM)- Syed Shah Areeb Hussain - 0541198
13/14
GANTT CHART
-
8/10/2019 Research Proposal (M04EKM)- Syed Shah Areeb Hussain - 0541198
14/14
Carleysmith, S.W., Dufton, A.M., and Altria, K.D. (2009) Implementing Lean Sigma in Pharmaceutical
Research and Development: A Review by Practitioners. R&D Management, 39 (1), 95106.
Chowdary, B. V. and George, D. (2011) Improvement of Manufacturing Operations at a
Pharmaceutical Company.Journal of Manufacturing Technology Management, 23 (1), 5675.
available from
Dermot, O. and Greene, A. (2006) Lean Manufacturing Practice in a cGMP Environment[online]
available from [29 December 2014]
DiMasi, J.A., Hansen, R.W., and Grabowski, H.G. (2003) The Price of Innovation: New Estimates of
Drug Development Costs.Journal of health economics, 22 (2), 15185.
Lanez, J.M., Schaefer, E., and Reklaitis, G.V. (2012) Challenges and Opportunities in Enterprise-
Wide Optimization in the Pharmaceutical Industry. Computers & Chemical Engineering, 47,
1928. available from
[13 December 2014]
Mukhopadhyay, S.K., Dwivedy, J., and Kumar, A. (1998) Design and Implementation of an
Integrated Production Planning System for a Pharmaceutical Manufacturing Concern in India.
Production Planning & Control, 9 (4), 391402.
Rother, M. and Shook, J. (2003) Learning to See: Value Stream Mapping to Add Value and Eliminate
Muda, Lean Enterprise Institute.
Thomas, H. (2005) Transforming the Pharma Industry: Lean Thinking Applied to the Pharmaceutical
Manufacturing. in World Congress of Chemical Engineering. held 2005
Weller, H.N., Nirschl, D.S., Petrillo, E.W., Poss, M.A., Andres, C.J., Cavallaro, C.L., Echols, M.M., Grant-
Young, K.A., Houston, J.G., Miller, A. V, and Swann, R.T. (2006) Application of Lean
Manufacturing Concepts to Drug Discovery: Rapid Analogue Library Synthesis.Journal of
combinatorial chemistry, 8 (5), 6649.
top related